دورية أكاديمية

Preclinical Development of PNT6555, a Boronic Acid–Based, Fibroblast Activation Protein-α (FAP)–Targeted Radiotheranostic for Imaging and Treatment of FAP-Positive Tumors.

التفاصيل البيبلوغرافية
العنوان: Preclinical Development of PNT6555, a Boronic Acid–Based, Fibroblast Activation Protein-α (FAP)–Targeted Radiotheranostic for Imaging and Treatment of FAP-Positive Tumors.
المؤلفون: Poplawski, Sarah E., Hallett, Robin M., Dornan, Mark H., Novakowski, Kyle E., Shuang Pan, Belanger, Anthony P., Quang-De Nguyen, Wengen Wu, Felten, Albert E., Yuxin Liu, Shin Hye Ahn, Hergott, Valerie S., Jones, Barry, Lai, Jack H., McCann, Joe A. B., Bachovchin, William W.
المصدر: Journal of Nuclear Medicine; Jan2024, Vol. 65 Issue 1, p100-108, 9p
قاعدة البيانات: Complementary Index
الوصف
تدمد:01615505
DOI:10.2967/jnumed.123.266345